We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Lucira Health Inc | NASDAQ:LHDX | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.4523 | 0.4451 | 0.448 | 0 | 00:00:00 |
From Feb 2023 to Feb 2025
By Sabela Ojea
Lucira Health Inc. on Friday received the U.S. Food and Drug Administration's emergency use authorization for its Covid-19 and Flu diagnostic test. Shares of the company, which provides at-home molecular tests and tele-health services for Covid-19, jumped 180% in after-hours trading.
Tegna Inc.'s $5.4 billion proposed sale to hedge fund Standard General L.P. will be further examined by an administrative law judge, the U.S. Federal Communications Commission said. Shares of the TV broadcaster dropped 26% in after-hours trading.
Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix
(END) Dow Jones Newswires
February 24, 2023 18:43 ET (23:43 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year Lucira Health Chart |
1 Month Lucira Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
